The opioid epidemic is driving a surge in infectious diseases such as HIV/AIDS, hepatitis, heart infections, and skin and soft tissue infections. Comprehensive treatment that addresses both substance use disorder and underlying infections can improve outcomes for patients.
Scientists discovered that microglia, a type of nervous system cell suspected to cause retinal damage, surprisingly had no damaging role during prion disease in mice. Microglia might delay disease progression, providing new insights into inherited photoreceptor degeneration diseases.
Despite advancements in disease research, neglected tropical diseases and others continue to require attention, with only a small proportion of new drugs addressing these conditions. Novel treatments like bedaquiline and tafenoquine offer hope, but much work remains to be done.
A clinical trial assessing the safety of experimental compound ANS-6637 has begun in healthy adults at the National Institutes of Health Clinical Center. The trial will evaluate how the compound affects opioid use disorder and provide groundwork for future studies to develop effective treatments for cravings, a major barrier to sobriety.
The Infectious Diseases Society of America (IDSA) has released updated guidelines for asymptomatic bacteriuria (ASB), suggesting that testing should be limited to high-risk patients. This shift aims to reduce unnecessary antibiotic treatment and minimize the risk of promoting antibiotic resistance.
A new assessment tool predicts the risk of developing chronic fatigue syndrome (CFS) in college students six months after contracting infectious mononucleosis. The study found that those with more severe mononucleosis were over three times more likely to meet CFS diagnostic criteria.
Recent research reveals that pollutants can alter animals' immune responses and decrease their resistance to infectious diseases. Chemical exposure in the womb has also been linked to increased risk of illnesses in children.
A study by the University of Kent found that annual disinfection of parakeet nests did not effectively reduce the spread of Psittacine Beak and Feather Disease. The research team recommends re-evaluating biosecurity measures to prioritize conservation objectives.
A study of 400 patients found that switching from intravenous to oral antibiotic therapy resulted in fewer deaths and complications over a median of 3.5 years. Patients who switched to oral treatment had better survival rates than those who remained on conventional intravenous therapy.
Experts warn of a surge in vector-borne diseases as Venezuela's humanitarian crisis worsens, with malaria cases increasing by 359% since 2010. The crisis is also leading to a resurgence of other diseases like Chagas disease and dengue, threatening public health gains in the country.
The review finds that while antibiotic development has improved, the most recently approved drugs represent modifications to existing classes rather than innovative approaches. Unmet needs persist due to a lack of treatment options for multidrug-resistant infections.
A Phase 1 human clinical trial has begun testing a freeze-dried, temperature-stable formulation of the experimental tuberculosis (TB) vaccine candidate ID93. The trial aims to determine if the single-vial formulation of ID93 and adjuvant GLA-SE is as effective as previously tested two-vial combination in inducing an immune response.
High research intensity relative to published global disease burden was found for influenza, HIV/AIDS, hepatitis C, and tuberculosis, while paratyphoid fever had low research intensity. Certain neglected tropical diseases such as Chagas disease, leishmaniasis, and leprosy also showed high research intensity.
Researchers have developed an ultrasensitive test that detects tau protein clusters, which are associated with Alzheimer's disease and chronic traumatic encephalopathy. The test has been shown to detect the protein in small amounts of brain tissue, making it a major advance for early diagnosis.
Researchers discovered that a drug initially developed for Alzheimer's disease has antibacterial properties, potentially breaking antibiotic resistance in bacteria. The findings suggest the drug could be repurposed to treat infectious diseases.
Scientists have discovered evidence of infectious prions in the eyes of deceased Creutzfeldt-Jakob disease (CJD) patients, which could lead to early diagnosis and treatment of this fatal neurodegenerative disease. The finding raises concerns about the safety of routine eye exams and corneal transplants.
The Infectious Diseases Society of America (IDSA) has released new guidelines for outpatient parenteral antimicrobial therapy (OPAT), emphasizing the importance of review by an infectious diseases specialist before starting treatment. Regular monitoring and blood tests are also recommended to ensure patient safety.
Research suggests that all infectious diseases follow a seasonal cycle, with outbreaks occurring at specific times of the year. Seasonality is driven by environmental factors such as temperature, humidity, and vector-borne diseases like Zika, which is influenced by mosquito proliferation in algae-filled waterbodies.
Researchers have developed a new vaccine strategy that offers partial protection against the highly contagious infectious bronchitis virus. The recombinant virus vaccine approach has potential to be more cost-effective and respond to emerging new virus strains, but further research is needed to develop a more robust vaccine.
Researchers analyzed over 57,000 publications on swine pathogens from 1966 to 2016, revealing emerging infectious diseases with increased research funding priority. Global networks of swine pathogen research were also mapped, showing regional collaboration patterns and colonial relationships.
Researchers developed a glow-in-the-dark paper strip that can detect the presence of infectious diseases using antibodies in blood, offering a quick and affordable alternative to traditional lab tests. The test measures antibody concentration by analyzing blue-green light produced through bioluminescence.
Researchers, led by Penn State's Steven Schiff, will develop innovative models to predict outbreaks of epidemic disease and provide real-time preventive treatment. Their approach aims to improve patient outcomes by incorporating historical microbiological surveillance data, geographic location, and environmental factors.
A large study in Shanghai, China found that socioeconomic development contributed to lower death rates for most diseases, likely due to lifestyle factors. Death rates from infectious diseases, maternal issues, and injuries decreased between 1974 and 2015.
The partnership aims to develop and conduct collaborative clinical research studies on young children with various immune system disorders. The collaboration provides joint training opportunities for physician-scientists and offers comprehensive pediatric clinical support.
Researchers develop 3-D tissue culture models to study host-microbe interactions and combat infectious diseases. The models mimic native tissues and offer valuable insights into mechanisms of infection, aiding in the design of effective vaccines and therapeutic agents.
A pilot project found that telehealth videoconferencing increased awareness of antibiotic stewardship principles and helped facilities implement more than two-thirds of recommendations. This study demonstrates how technology can provide access to expert knowledge and practices for smaller facilities.
A new study has developed highly sensitive and specific assays to detect infectious agents in pigs, a crucial step towards ensuring the safety of xenotransplantation. The assays were validated on over 300 pig specimens and showed promising results, suggesting they can identify potential pathogens in donor pigs.
HIV/AIDS research has led to significant advances in heart disease, hepatitis, and cancer. Scientists have better understood the vital role of CD4+ T cells in thwarting other infectious diseases and certain cancers.
The Central Africa region is experiencing rapid urbanization and economic growth, making it more vulnerable to explosive infectious disease outbreaks. The authors note that efforts to build up health care infrastructure are critically needed to mitigate or prevent a large outbreak of Ebola or other infectious diseases in the region.
A new mathematical model reveals how social interactions influence the emergence of infectious diseases, allowing for better anticipation and prevention of outbreaks. The study suggests that understanding human behavior can aid in preventing the evolution of more virulent pathogen strains.
Challenges facing ID physician scientists include inadequate funding for fellowship opportunities and steep compensation disparities, leading to a decline in trainees pursuing careers as physician researchers. To address this, medical societies recommend expanded mentorship, training opportunities, and workforce diversity measures.
A study published in Clinical Infectious Diseases identified nine clusters of respiratory infections in Uganda, including one potentially linked to UK tourism. The researchers used a genetic sequencing method called VirCapSeq-VERT to analyze nasal and throat swabs, providing detailed information on viral pathogens.
A new study published in The Journal of Infectious Diseases suggests that obesity may play a role in how the flu spreads. Obese adults infected with flu shed the virus for a longer time than non-obese adults, potentially increasing the opportunity for transmission to others.
The National Academies have released a report on the intersection of opioid use disorder and infectious diseases, highlighting the urgent need for integrated treatment strategies. The report suggests five action steps to target both opioid use disorder and its resulting rise in infectious diseases, including screening for OUD, implemen...
Researchers at NIAID developed a 3D model of the 1918 H1 pandemic influenza virus using cryo-electron microscopy. The study found that VLPs are mostly composed of hemagglutinin proteins, influencing vaccine efficacy.
A new lab diagnosis guide from IDSA and ASM aims to help healthcare providers accurately diagnose infectious diseases with rapid molecular testing. The guide provides detailed guidance on test selection, specimen collection, and laboratory management to ensure accurate diagnosis and treatment.
Removal of tonsils and adenoids in childhood increases long-term risks of respiratory, allergic, and infectious diseases. The study suggests delaying surgery if possible to aid normal immune system development and reduce potential later-life disease risks.
Active case finding is recommended for hepatitis B and C, HIV, and tuberculosis in prison settings. The approach aims to diagnose infectious diseases early and interrupt transmission. Key findings include a high burden of communicable diseases among prisoners, leading to increased risk of transmission upon release.
Scientists warn of increased infectious diseases transmitted through vectors in the coming decades. The Asian tiger mosquito, introduced via trade and tourism, has not yet filled its ecological niche globally, posing a threat to regional health.
Researchers discovered that microglia can defend against prion infections by trapping and destroying aggregated prion proteins. Eliminating microglia with a specific drug accelerated disease progression in infected mice. The findings suggest targeting microglia to slow the course of prion diseases, including Alzheimer's and Parkinson's.
A pioneering paper provides a practical guide for infection control in clinics, emphasizing the importance of hand hygiene, injection safety, cleaning, sterilization, and high-level disinfection. The guide promotes a proactive approach to infection prevention and control, empowering patients to hold healthcare providers accountable.
A unique initiative will bring together over 250 researchers at McGill and the MUHC to develop innovative solutions to infectious diseases. The project will focus on four major themes: antimicrobial resistance, emerging and re-emerging diseases, infections in vulnerable populations, and diseases of altered immunity.
The study demonstrates the efficacy of a single dose of NDV-3A in reducing recurrences of vaginitis in patients with RVVC, with younger patients showing higher efficacy rates. The vaccine also generates rapid and robust immune responses.
A National Institutes of Health (NIH) study has found no evidence of transmissibility of chronic wasting disease in cynomolgus macaque monkeys. The research, published in the Journal of Virology, involved exposing 14 macaques to brain matter from CWD-infected deer and elk over a period of up to 13 years.
A novel computational method reveals that EBV protein EBNA2 activates human genes associated with increased risk for autoimmunity, including systemic lupus erythematosus and multiple sclerosis. Researchers propose potential therapies to interrupt this process.
Global rates of mental disorders among children remain stable, with prevalence high and constant across emerging regions. Mental disorders surpassed infectious diseases as main causes of disability-adjusted life years (DALYs) in children, according to a new study.
Research from the University of Copenhagen found a U-shaped relationship between HDL cholesterol levels and risk of infectious diseases. Individuals with both very low and very high HDL cholesterol had high risks of hospitalization and death from infectious diseases, including gastroenteritis and pneumonia.
A study published in JAMA Network found that deaths due to most infectious diseases decreased in the US over a 34-year period. However, significant variations in mortality rates were observed across different counties, with lower respiratory infections and HIV/AIDS being major contributors to these disparities.
A new study reveals that diarrheal diseases are becoming a major public health concern in the US, with rates increasing substantially between 1980 and 2014. Diarrheal disease deaths were ranked as the second-leading cause of all infectious disease mortality, behind lower respiratory infections such as pneumonia and bronchitis.
A study published in Open Forum Infectious Diseases found that patients with drug-resistant infections who received consultation from ID specialists had a 50% lower 30-day mortality rate. ID consultation was also associated with reduced mortality and hospital readmissions for certain types of resistant bacteria.
A Phase 3 clinical trial funded by the National Institute of Allergy and Infectious Diseases found consistent and dramatic improvements in quality of life among participants with type 1 diabetes who had frequent severe hypoglycemia. Islet recipients also reported better overall health status despite needing lifelong treatment.
Researchers estimate the risk of infectious disease transmission on airplanes, finding that movement patterns can facilitate disease spread. Passengers seated within one row and two seats lateral to an infected individual have a high probability of infection, while others are at low risk.
Scientists from NIAID exposed research mice to brain samples from three people who died from a familial prion disease. Two mutations, Y226X and G131V, were found to be transmissible to mice. The finding highlights the hardiness of prion infectivity and potential risks associated with prion transmission.
Researchers from NIAID highlight the potential of monoclonal antibodies in treating and preventing emerging infectious diseases. These therapies have shown promise in clinical trials, such as the Ebola outbreak, and may offer a more targeted approach to infection prevention and treatment.
The National Institute of Allergy and Infectious Diseases (NIAID) has unveiled a strategic plan to develop a universal influenza vaccine. The plan focuses on three key areas: improving understanding of influenza transmission, characterizing protective immunity, and designing universal vaccines.
The National Institute of Allergy and Infectious Diseases is supporting clinical trials testing monoclonal antibodies as preventive therapies for antibiotic-resistant infections. The trials aim to prevent pneumonia caused by Pseudomonas aeruginosa and Staphylococcus aureus, two bacteria posing a significant threat to human health.
Researchers developed a rapid test to diagnose Parkinson's and dementia with Lewy bodies using cerebral spinal fluid samples. The test showed high accuracy in detecting these diseases within two days, outperforming related assays.
A new University of Maryland-led study reveals that people with the flu can generate infectious aerosols even when not coughing, and especially during the first days of illness. This finding suggests that airborne transmission may be a significant route of flu spread.
Human antibodies manufactured from transchromosomic cattle have been found safe in healthy volunteers, suggesting a potential novel technique for rapidly producing antibodies for passive immunotherapy against emerging infectious diseases like MERS. The treatment, SAB-301, was well-tolerated and showed promise in countering the virus.
A report by the American College of Cardiology recommends prioritizing US resources toward detecting and treating cardiovascular disease, while maintaining efforts to eradicate infectious diseases. The report aims to save lives and contribute to worldwide economic prosperity through a strong global health strategy.